Development of drug delivery systems for the dermal application of therapeutic DNAzymes.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International journal of pharmaceutics

• Publication date

  2012-07-15

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2012.04.034PMID 22531847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective effect of drug delivery systems against the enzymatic degradation of dermally applied DNAzyme.

  2011cited by this paper
• Development of multiple W/O/W emulsions as dermal carrier system for oligonucleotides: effect of additives on emulsion stability.

  2010cited by this paper
• Topical delivery of interleukin‐13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis

  2009cited by this paper
• Charakterisierung GATA-3-spezifischer DNAzyme und Analyse der therapeutischen Wirksamkeit in experimentellen Modellen des allergischen Asthma bronchiale

  2009cited by this paper
• Role of GATA-3 in allergic diseases.

  2008cited by this paper
• Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme.

  2008cited by this paper
• The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.

  2008cited by this paper
• Development of an in vitro Skin Permeation Model Simulating Atopic Dermatitis Skin for the Evaluation of Dermatological Products

  2007cited by this paper
• GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors

  2006cited by this paper
• Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review Article.

  2005cited by this paper
• In vitro selection, characterization, and application of deoxyribozymes that cleave RNA

  2005cited by this paper
• Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation.

  2004cited by this paper
• The Interaction between GATA Proteins and Activator Protein-1 Promotes the Transcription of IL-13 in Mast Cells1

  2004cited by this paper
• W/O/W multiple emulsions with diclofenac sodium.

  2004cited by this paper
• Optimization of a thermally reversible W/O/W multiple emulsion for shear-induced drug release.

  2003cited by this paper
• Particle size of liposomes influences dermal delivery of substances into skin.

  2003cited by this paper
• Structural Rearrangements of the 10–23 DNAzyme to β3 Integrin Subunit mRNA Induced by Cations and Their Relations to the Catalytic Activity*

  2003cited by this paper
• Ragweed-induced expression of GATA-3, IL-4, and IL-5 by eosinophils in the lungs of allergic C57BL/6J mice.

  2002cited by this paper
• Skin permeation enhancement effect and skin irritation of saturated fatty alcohols.

  2002cited by this paper
• Influence of microemulsions on cutaneous drug delivery.

  2002cited by this paper
• Formulation of shear rate sensitive multiple emulsions.

  2001cited by this paper
• Cellular and immunologic mechanisms in atopic dermatitis.

  2001cited by this paper
• Atopic dermatitis: new insights and opportunities for therapeutic intervention.

  2000cited by this paper
• The delivery of antisense therapeutics.

  2000cited by this paper
• Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. European Cosmetic, Toiletry and Perfumery Association.

  1999cited by this paper
• Multiple emulsions containing rifampicin.

  1999cited by this paper
• Biological barriers to cellular delivery of lipid-based DNA carriers.

  1999cited by this paper
• Multiple emulsions containing rifampicin.

  1999cited by this paper
• Requirement for IL-13 independently of IL-4 in experimental asthma

  1998cited by this paper
• Mechanism and utility of an RNA-cleaving DNA enzyme.

  1998cited by this paper
• The TH1/TH2 paradigm in allergy.

  1998cited by this paper
• Requirement for IL-13 independently of IL-4 in experimental asthma.

  1998cited by this paper
• Modification of drug penetration into human skin using microemulsions

  1997cited by this paper
• Delivery of a hydrophilic solute through the skin from novel microemulsion systems

  1997cited by this paper
• The effect of co-solvents on the antibacterial activity of paraben preservatives

  1995cited by this paper
• T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice.

  1995cited by this paper
• Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal antiinflammatory drugs.

  1995cited by this paper
• Enhanced Transdermal Delivery of Diazepam by Submicron Emulsion (SME) Creams

  1995cited by this paper
• Vehicle influence on in vitro release of metronidazole: role of w/o/w multiple emulsion

  1994cited by this paper
• A topical W/O/W multiple emulsion containing several active substances : formulation, characterization and study of release

  1993cited by this paper
• Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription

  1993cited by this paper
• Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription.

  1993cited by this paper
• Availability and activity of preservatives in emulsified systems.

  1991cited by this paper
• Evidence that Oleic Acid Exists in a Separate Phase Within Stratum Corneum Lipids

  1991cited by this paper
• Comparison of methods for determining DNase and phosphatase activities of staphylococci

  1989cited by this paper
• Preparation of and drug release from W/O/W type double emulsions containing anticancer agents using an oily lymphographic agent as an oil phase.

  1987cited by this paper
• The formulation and stability of multiple emulsions

  1982cited by this paper
• Some features of breakdown in water-in-oil-in-water multiple emulsions

  1981cited by this paper
• Production of coagulase, deoxyribonuclease and heat-stable deoxyribonuclease by canine isolates of staphylococci.

  1978cited by this paper
• An attempt at preparing water-in-oil-in-water multiple-phase emulsions

  1976cited by this paper
• EFFECTIVENESS OF ANTIBACTERIAL AGENTS PRESENTLY EMPLOYED IN OPHTHALMIC PREPARATIONS AS PRESERVATIVES AGAINST PSEUDOMONAS AERUGINOSA.

  1963cited by this paper

• (W/O/W) Double Emulsions-Filled Chitosan Hydrogel Beads for Topical Application

  2025cites this paper
• A novel 5-Fluorocuracil multiple-nanoemulsion used for the enhancement of oral bioavailability in the treatment of colorectal cancer

  2022cites this paper
• Topical Lipid Based Drug Delivery Systems for Skin Diseases: A Review

  2020cites this paper
• Phonophoretic application of a glucosamine and chondroitin nanoemulsion for treatment of knee chondropathies.

  2020cites this paper
• Clotrimazole multiple W/O/W emulsion as anticandidal agent: Characterization and evaluation on skin and mucosae.

  2019cites this paper
• Dermal delivery of therapeutic DNAzymes via chitosan hydrogels

  2019cites this paper
• Enzymes as Therapeutic Agents in Human Disease Management

  2019cites this paper
• Tetrahedral DNA Nanostructure-Delivered DNAzyme for Gene Silencing to Suppress Cell Growth.

  2019cites this paper
• Soft multiple emulsions demonstrating reversible freeze-thawing capacity and enhanced skin permeability of diclofenac sodium

  2018cites this paper
• Delivery of therapeutic RNA-cleaving oligodeoxyribonucleotides (deoxyribozymes): from cell culture studies to clinical trials

  2017cites this paper
• Recent advances in DNAzyme-based gene silencing

  2017cites this paper
• Degradation and protection of DNAzymes on human skin.

  2016cites this paper
• Nanoparticles for Treatment of Atopic Dermatitis

  2016cites this paper
• The molecular assembly of the ionic liquid/aliphatic carboxylic acid/aliphatic amine as effective and safety transdermal permeation enhancers.

  2016cites this paper
• Enzyme Therapy: Current Perspectives.

  2016cites this paper
• Individual analysis of epidermal barrier lipids and their composition in subjects with atopic dermatitis. Investigations using Lipbarvis®, a non-invasive sampling technique, and subsequent electron microscopic (LBV TEM®) and HPTLC analysis (LBV Lip®)

  2015cites this paper
• Water-in-Oil-in-Water Nanoencapsulation Systems

  2015cites this paper
• FACULTAD DE FARMACIA UNIVERSIDAD COMPLUTENSE

  2015cites this paper
• Development of a protective dermal drug delivery system for therapeutic DNAzymes.

  2015cites this paper
• Nanomedicine strategies for targeting skin inflammation.

  2014cites this paper
• Double w/o/w nanoemulsion of 5-fluorouracil for self-nanoemulsifying drug delivery system

  2014cites this paper
• Natural polymer‐stabilized multiple water‐in‐oil‐in‐water emulsions: a novel dermal drug delivery system for 5‐fluorouracil

  2014cites this paper
• Development and validation of an alternative disturbed skin model by mechanical abrasion to study drug penetration

  2014cites this paper
• Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries.

  2014cites this paper
• DNAzyme delivery approaches in biological settings.

  2013cites this paper
• Evaluation and quantification of spectral information in tissue by confocal microscopy

  2012cites this paper